Brief: Newbury Pharmaceuticals Adds Buspirone Tablets To Its Portfolio

Newbury Pharmaceuticals AB

02/02/2023 06:57

Feb 2 (Reuters) - Newbury Pharmaceuticals AB
 NEWBRY.ST :
    * NEWBURY PHARMACEUTICALS IS STRENGTHENING ITS PORTFOLIO
WITH
BUSPIRONE TABLETS
    * WE AIM TO LAUNCH BUSPIRONE IN SWEDEN AND FINLAND WHERE
TOTAL
ANNUAL VALUE OF MARKET IS ESTIMATED TO BE 1,5 MEUR

Source text for Eikon:  ID:nMFNc41XCG 
Further company coverage:  NEWBRY.ST 
 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))